Publications by authors named "Kerstin Claesson"

Claim this Profile
[
[New recommendations in hospital-acquired pneumonia].
Håkan Hanberger, Kerstin Claesson

Lakartidningen· February 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[Threatened treatment of bacterial sexually transmitted infections. The Medical Products Agency and the Public Health Agency issues new recommendation].
Carin Anagrius, Kerstin Claesson

Lakartidningen· February 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[New guidelines on cardiovascular prevention with drugs. The Medical Products Agency recommends risk assessment before choosing a treatment].
Kerstin Claesson, Thomas Kahan, Peter M Nilsson

Lakartidningen· October 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
[
[New treatment recommendations: Management of pharyngo-tonsillitis in ambulatory care].
Bo Aronsson, Kerstin Claesson

Lakartidningen· April 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tacrolimus-based, steroid-free regimens in renal transplantation: 3-year follow-up of the ATLAS trial.
Bernhard K Krämer, Marian Klinger, Štefan Vítko, Maciej Glyda, Karsten Midtvedt, Kerstin Claesson

Transplantation· September 2012

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
CMV-specific T-cell immunity, viral load, and clinical outcome in seropositive renal transplant recipients: a pilot study.
Fredrik Sund, Anna-Karin Lidehäll, Kerstin Claesson, Aksel Foss, Thomas H Tötterman

Clin Transplant· October 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Tacrolimus combined with two different corticosteroid-free regimens compared with a standard triple regimen in renal transplantation: one year observational results.
Bernhard K Krämer, Marian Klinger, Zbigniew Wlodarczyk, Marek Ostrowski, Karsten Midvedt, Kerstin Claesson

Clin Transplant· September 2010

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sirolimus therapy after early cyclosporine withdrawal reduces the risk for cancer in adult renal transplantation.
Josep M Campistol, Josette Eris, Rainer Oberbauer, Peter Friend, Brian Hutchison, Kerstin Claesson

J Am Soc Nephrol· February 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Two corticosteroid-free regimens-tacrolimus monotherapy after basiliximab administration and tacrolimus/mycophenolate mofetil-in comparison with a standard triple regimen in renal transplantation: results of the Atlas study.
Stefan Vítko, Marian Klinger, Kaija Salmela, Zbigniew Wlodarczyk, Gunnar Tydèn, Kerstin Claesson

Transplantation· December 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
T
Trimethoprim-sulphamethoxazole does not affect the pharmacokinetics of sirolimus in renal transplant recipients.
Ylva Böttiger, Christina Brattström, Lars Bäckman, Kerstin Claesson, James T Burke

Br J Clin Pharmacol· November 2005

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Sirolimus-based therapy following early cyclosporine withdrawal provides significantly improved renal histology and function at 3 years.
Alfredo Mota, Manuel Arias, Eero I Taskinen, Timo Paavonen, Yves Brault, Kerstin Claesson

Am J Transplant· June 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term improvement in renal function with sirolimus after early cyclosporine withdrawal in renal transplant recipients: 2-year results of the Rapamune Maintenance Regimen Study.
Rainer Oberbauer, Henri Kreis, Robert W G Johnson, Alfredo Mota, Kerstin Claesson

Transplantation· July 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Health-related quality-of-life outcomes of sirolimus-treated kidney transplant patients after elimination of cyclosporine A: results of a 2-year randomized clinical trial.
Rainer Oberbauer, Brian Hutchison, Josette Eris, Manuel Arias, Kerstin Claesson

Transplantation· April 2003

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis